Stockreport

ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]

ReShape Lifesciences, Inc.  (RSLS) 
US:NASDAQ Investor Relations: ir.enteromedics.com
PDF Conference Call to be Held at 4:30 pm ET Today IRVINE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led [Read more]